Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skyepharma | LSE:SKP | London | Ordinary Share | GB00B3BFNB64 | ORD 100P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 443.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2016 13:03 | Hi heffermj welcome back, POB | ![]() pooroldboy55 | |
11/1/2016 11:35 | The recent rise caused me to revisit the board after many years - good to see some of the long termers from back in the day are still around. My buys were at £48 all the way down to £40 so you can see I am well underwater and had written this off. I remember Dunderheed, POB, Raven (plonker) etc but I thought the avatar Polaris was a frequent/knowledgabl | heffermj | |
11/1/2016 11:33 | Much more to come here. Just a glance ahead into the near future as many triggers for further earnings upgrades and that's the real driver of a share-price ala DTG | gersemi | |
11/1/2016 11:29 | Good report,very positive. | ![]() kfp | |
11/1/2016 10:07 | SKP gets a mention | ![]() soundbuy | |
11/1/2016 09:58 | chrisgail Calm down only a comment,I have also had SKP since 1996.Agree with diesel | ![]() kfp | |
11/1/2016 09:39 | Surprisingly scant update, solid progress but focus on pipeline is appropriately key. Over the last couple of years I've guessed at exit targets and although I have shaved a few of my holding still believe this has further to go. With the cash they are generating a divvy policy is now very possible in the not to distant future. | ![]() diesel | |
11/1/2016 09:31 | kfp. It's a trading update, we should only expect an update on present products/production/ | chrisgail | |
11/1/2016 09:31 | Onwards and upwards.Well done to those who added at the lows. | ![]() wigwammer | |
11/1/2016 09:28 | "under review" I'd imagine it would be +ive............upgr Previous rec on 26-Nov-15 was 'Hold' and a TP of 355.00p. | ![]() soundbuy | |
11/1/2016 08:52 | Nothing on any of the other projects other than SKP 2075. | ![]() kfp | |
11/1/2016 08:47 | FinnCap = SKP "under review" whatever that means ,I presume it means an upgrade ? | ![]() kfp | |
11/1/2016 07:38 | That'll do :) | ![]() soundbuy | |
08/1/2016 15:40 | Next week maybe another run at the £4 wall, providing the update is positive ? | ![]() kfp | |
08/1/2016 11:20 | Vectura riding high today on completion of clinical trial in US of their generic Asthma inhaler---wish Fluti could get movement over there. | ![]() cap160 | |
08/1/2016 11:15 | Stefil say's buy, target price 460p. | ![]() kfp | |
07/1/2016 19:00 | Pacira forecasting 240m so looks like we're going to miss the 250m millstone payment .But 19 percent growth last quarter so back on track | ![]() best1467 | |
07/1/2016 13:08 | Understandable drop today, but is it just on light uk trading, the big movements seem to take place pm my guess is it will recover a lot of this fall later today. | ![]() diesel | |
06/1/2016 19:28 | I thought it was 6p but so long ago I'm old now and can't remember. | ![]() kfp | |
06/1/2016 18:59 | Lol--me too. I think I bought these as Black and Edgington for something like 3p. | ![]() cap160 | |
06/1/2016 18:51 | I can remember when a rise of 23p would have doubled the share price ! | ![]() kfp | |
06/1/2016 18:30 | Falling health budgets forces switch to cheaper alternatives from Seretide to Flutiform which is why SKP is so highly rated. It seems Flutiform is just as effective as well. If SKP can get approval for Flutiform for under 16's (-12 yrs) then demand would be boosted significantly | gersemi | |
06/1/2016 18:27 | Possibly, with all important milestones dependent on good sales figures | ![]() cap160 | |
06/1/2016 18:23 | But would news about a partner send SKP shares up 6% a day ? | ![]() kfp |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions